HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Daniel J Drucker Selected Research

liraglutide

1/2015Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes.
3/2014The protective roles of GLP-1R signaling in diabetic nephropathy: possible mechanism and therapeutic potential.
1/2013A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity.
4/2010Liraglutide.
4/2010Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation.
9/2009Glucagon-like peptide-1 receptor activation modulates pancreatitis-associated gene expression but does not modify the susceptibility to experimental pancreatitis in mice.
4/2009GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice.
11/2006The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Daniel J Drucker Research Topics

Disease

21Body Weight (Weight, Body)
06/2015 - 03/2003
14Obesity
06/2015 - 05/2006
10Hyperglycemia
11/2015 - 02/2003
10Type 2 Diabetes Mellitus (MODY)
06/2015 - 01/2002
10Weight Loss (Weight Reduction)
10/2014 - 11/2006
9Hypoglycemia (Reactive Hypoglycemia)
02/2015 - 10/2003
6Inflammation
02/2014 - 05/2006
6Insulin Resistance
10/2013 - 12/2005
6Neoplasms (Cancer)
07/2011 - 07/2002
5Hyperplasia
04/2013 - 04/2010
4Myocardial Infarction
02/2015 - 04/2009
4Ischemia
04/2010 - 05/2008
3Diabetes Mellitus
07/2015 - 01/2002
3Anorexia
04/2013 - 01/2005
3Weight Gain
07/2011 - 11/2006
2Hypertrophy
02/2015 - 01/2013
2Short Bowel Syndrome
02/2015 - 01/2014
2Necrosis
01/2013 - 01/2003
2Colitis
06/2012 - 02/2002
2Enteritis
03/2012 - 02/2002
2Colonic Neoplasms (Colon Cancer)
09/2011 - 10/2008
2Pancreatitis
07/2011 - 09/2009
2Glucose Intolerance
01/2011 - 02/2004
2Mucositis
10/2008 - 02/2002
2Reperfusion Injury
05/2008 - 02/2002
2Nausea
11/2006 - 01/2002
2Intestinal Diseases (Diseases, Intestinal)
11/2005 - 02/2002
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2015
1Colonic Polyps
03/2015
1Overweight
01/2015
1Diabetes Complications
01/2015
1Cardiomyopathies (Cardiomyopathy)
08/2014
1Cardiovascular Diseases (Cardiovascular Disease)
05/2014
1Diabetic Nephropathies (Diabetic Nephropathy)
03/2014
1Albuminuria
03/2014
1Endotoxemia
02/2014
1Hyperinsulinism (Hyperinsulinemia)
02/2014
1Bradycardia
10/2013
1Heart Neoplasms
01/2013
1Fibrosis (Cirrhosis)
01/2013
1Atherosclerosis
01/2013

Drug/Important Bio-Agent (IBA)

34Glucagon-Like Peptide 1 (GLP 1)IBA
07/2015 - 01/2002
30Glucose (Dextrose)FDA LinkGeneric
01/2015 - 01/2002
17glucagon-like peptide receptor (receptor, glucagon-like peptide)IBA
10/2014 - 05/2006
15Insulin (Novolin)FDA Link
11/2015 - 02/2004
15Glucagon (Glukagon)FDA Link
06/2015 - 07/2002
11IncretinsIBA
05/2014 - 01/2002
8liraglutideFDA Link
01/2015 - 11/2006
7Glucagon Receptors (Glucagon Receptor)IBA
06/2015 - 10/2005
7exenatide (Byetta)FDA Link
03/2015 - 01/2003
7HormonesIBA
03/2014 - 07/2002
5PeptidesIBA
06/2013 - 02/2002
4Streptozocin (Streptozotocin)FDA Link
11/2015 - 11/2008
4GLP-2 receptorIBA
02/2015 - 10/2008
4Metformin (Glucophage)FDA LinkGeneric
01/2013 - 01/2002
4sitagliptin (Januvia)FDA Link
04/2010 - 11/2006
3Dextran SulfateIBA
06/2012 - 02/2002
3Blood Glucose (Blood Sugar)IBA
11/2007 - 01/2002
3Proglucagon (Glucagon Precursors)IBA
11/2005 - 07/2002
2salicylhydroxamic acid (SHAM)IBA
03/2014 - 02/2003
2LeptinIBA
07/2013 - 08/2009
2Carbon MonoxideIBA
07/2013 - 10/2009
2GastrinsIBA
07/2013 - 10/2003
2Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
07/2013 - 01/2002
2medullary Thyroid cancerIBA
09/2011 - 07/2011
2Calcitonin (Calcitonin, Eel)FDA LinkGeneric
04/2010 - 02/2008
2Glycogen Synthase Kinase 3IBA
10/2008 - 10/2007
2vildagliptinIBA
12/2007 - 11/2006
1Fibroblast Growth Factor 7FDA Link
03/2015
1p38 Mitogen-Activated Protein KinasesIBA
02/2015
1teduglutideIBA
02/2015
1Atrial Natriuretic Factor (ANF)IBA
01/2015
1Peptide Receptors (Peptide Receptor)IBA
01/2015
1SodiumIBA
01/2015
1CholesterolIBA
01/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2014
1renal NAD(P)H oxidaseIBA
03/2014
1BIIE 0246IBA
03/2014
1Superoxides (Superoxide)IBA
03/2014
1NADPH Oxidase (NAD(P)H oxidase)IBA
03/2014
1LipopolysaccharidesIBA
02/2014
1Adrenergic Agonists (Adrenergic Receptor Agonist)IBA
10/2013
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2013
1Methacholine Chloride (Methacholine)FDA Link
10/2013
1Methoxamine (Methoxamine Hydrochloride)FDA Link
10/2013
1Islet Amyloid PolypeptideIBA
07/2013
1Proteins (Proteins, Gene)IBA
07/2013
1Peptide Hormones (Polypeptide Hormones)IBA
07/2013
1FructoseIBA
04/2013
1NF-kappa B (NF-kB)IBA
01/2013
1Apolipoproteins E (ApoE)IBA
01/2013
1AMP-Activated Protein KinasesIBA
01/2013

Therapy/Procedure

2Parenteral Nutrition
02/2015 - 01/2014
2Ligation
02/2015 - 04/2010
2Therapeutics
07/2011 - 08/2009
2Injections
04/2010 - 11/2006
2Drug Therapy (Chemotherapy)
10/2008 - 02/2002
1Gastric Bypass (Roux-en-Y Gastric Bypass)
03/2014
1Bariatric Surgery
07/2013
1Gastrectomy
07/2013